Pfizer, BioNTech Report High Efficacy of COVID-19 Booster Shot in Study Pfizer, BioNTech Report High Efficacy of COVID-19 Booster Shot in Study

A booster dose of the COVID-19 vaccine developed by Pfizer and German partner BioNTech restored efficacy to 95.6% against disease caused by the virus, including the Delta variant.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news